Back
ESC Premium Access

Liver stiffness assessed by fibrosis-4 index; noninvasive marker using serum biomarkers is associated with right ventricular function and cardiovascular prognosis in HFpEF

Session: Poster Session 3 - Heart failure treatment, HFpEF, HFrEF
Topic: Biomarkers
Speaker: Doctor M. Nakashima (Okayama, JP)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Doctor Mitsutaka Nakashima

Okayama University Hospital, Okayama (Japan)
0 follower

9 more presentations in this session

Trans-catheter or surgical mitral valve procedure versus conservative treatment in heart failure patients with preserved ejection fraction

Speaker: Doctor X. Sun (Rochester, US)

Access
Abstract
Slides
Like
Thumbnail

Inhaled iloprost improves echocardiographic myocardial performance during exercise in heart failure with preserved ejection fraction

Speaker: Doctor C. Huang (Taipei, TW)

Access
Abstract
Like
Thumbnail

Impaired right ventricular force-frequency relationship in patients with heart failure is associated with diastolic dysfunction and worse functional capacity

Speaker: Doctor A. Giammarresi (Bergamo, IT)

Access
Abstract
Slides
Like
Thumbnail

Clinical features associated with the development of diastolic dysfunction

Speaker: Miss S. Bots (Utrecht, NL)

Access
Abstract
Slides
Like
Thumbnail

Analysis of myocardial work: a potential new tool for a better assessment of left ventricular function

Speaker: Associate Professor R. Rimbas (Bucharest, RO)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 3 - Heart failure treatment, HFpEF, HFrEF

Speakers: Doctor M. Nakashima, Doctor X. Sun, Doctor C. Huang, Doctor A. Giammarresi, Miss S. Bots...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources